Thermo Fisher Scientific Wins Three R&D 100 Awards Category: Corporate
Thermo Fisher Scientific Inc. has announced that three of its analytical instruments were included on the R&D Magazine list of the year’s top 100 technology innovations. Known as the “Oscars of Innovation,” the R&D 100 recognises the best new products across industry, academia and government-sponsored research.
“Innovation is a key component of our growth strategy and critical to fulfilling our mission, which is to enable our customers to make the world healthier, cleaner and safer,” said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. “The R&D 100 awards recognise our commitment to technology development and our focus on giving customers the tools they need to achieve their own goals for innovation and productivity.”
The award-winning products are
• Thermo Scientific Delta Ray, an isotope ratio infrared spectrometer that enables scientists to monitor volcanos, greenhouse gases, plant ecology, and carbon capture and storage, among other applications for CO2 analysis. The Delta Ray spectrometer gives scientists real-time results at the sample source, eliminating bottlenecks created when transporting samples from the field to the lab.
• Thermo Scientific RIIDEye X, a handheld radiation isotope identifier designed to detect gamma and neutron radiation sources and provide information on location, type and quantity. The RIIDEye X delivers fast, accurate readings in harsh operating conditions, making it ideal for military personnel, first responders and field-based researchers.
• Thermo Scientific Dionex ERS 500, the first electrolytically regenerated, high-capacity membrane suppressor that eliminates the need for chemical reagents during ion chromatography analysis. Designed for use in environmental, food and beverage, and pharmaceutical markets, the ERS 500 suppressor is more pressure tolerant than previous technologies, a feature critical to long-term reliability.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance